Skip to main content
. 2011 Dec;6(12):2894–2900. doi: 10.2215/CJN.03710411

Table 4.

Univariate and multivariate logistic regression for association of variables with occurrence of any infection as the outcome

Unadjusted OR P 95% CI
Lower Limit Upper Limit
Univariate
    non-RIT versus RIT 0.92 0.68 0.61 1.39
    PRA category 0.96 0.77 0.76 1.23
    follow-up (days) 1.00 0.64 1.00 1.00
    vintage 1.00 0.55 1.00 1.00
    DD versus LD 1.53 0.05 1.01 2.34
    induction agent 1.00 0.98 0.79 1.26
    lymphocyte depletion 1.34 0.16 0.89 2.04
    race 0.90 0.27 0.74 1.09
    age (years) 1.02 0.02 1.00 1.03
    gender 1.45 0.08 0.95 2.21
    DM and/or HTNa 1.12 0.07 0.99 1.28
    acute rejection 1.57 0.08 0.95 2.59
Multivariate
    lymphocyte depletion 1.18 0.47 0.75 1.87
    DD versus LD 1.37 0.16 0.88 2.12
    age (years) 1.02 0.06 1.00 1.03
    gender 1.52 0.06 0.98 2.34
    DM and/or HTNa 1.09 0.27 0.94 1.25
    acute rejection 1.64 0.06 0.98 2.76

The reference group for diabetes mellitus and/or hypertension is all other kidney diseases (glomerulonephritis, cystic, other, and unknown). The reference group for gender is male. DD, deceased donor; LD, living donor; OR, odds ratio; PRA, panel reactive antibodies; RIT, rituximab; DM, diabetes mellitus; HTN, hypertension; CI, confidence interval.

a

The presence of diabetes mellitus and/or hypertension as the cause of end-stage renal disease.